Cargando…
Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis
The alterations of MET have been detected in non-small-cell lung cancer (NSCLC). However, the prognostic impact of MET gene copy number gain (CNG) has not been consistent among studies. We performed this meta-analysis to evaluate the prognostic value of high MET CNG in patients with NSCLC. A systema...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968772/ https://www.ncbi.nlm.nih.gov/pubmed/29805710 http://dx.doi.org/10.7150/jca.24980 |
_version_ | 1783325840223764480 |
---|---|
author | Kim, Jung Han Kim, Hyeong Su Kim, Bum Jun |
author_facet | Kim, Jung Han Kim, Hyeong Su Kim, Bum Jun |
author_sort | Kim, Jung Han |
collection | PubMed |
description | The alterations of MET have been detected in non-small-cell lung cancer (NSCLC). However, the prognostic impact of MET gene copy number gain (CNG) has not been consistent among studies. We performed this meta-analysis to evaluate the prognostic value of high MET CNG in patients with NSCLC. A systematic computerized search of the electronic databases including PubMed, EMBASE, Google scholar, and Cochrane Library (up to November 2017) was carried out. From twenty-one studies, 7,647 patients were included in the pooled analysis of hazard ratios (HRs) with 95% confidence intervals (CIs) for disease-free survival or overall survival. Compared with patients with NSCLC showing low MET CNG, those with tumors harboring high MET CNG showed significantly worse survival (HR = 1.45, 95% CI: 1.16-1.80, p = 0.001). Subgroup analyses showed that high MET CNG significantly correlated with a poor prognosis especially in patients with adenocarcinoma (HR = 1.41, 95% CI: 1.11-1.79, p = 0.005) and Asian populations (HR = 1.58, 95% CI: 1.32-1.88, p < 0.00001). In conclusion, this meta-analysis indicates that high MET CNG is an adverse prognostic factor in patients with NSCLC. Subgroup analyses suggest that high MET CNG is associated with a worse prognosis, especially in patients with adenocarcinoma and Asian populations. However, large prospective studies using standardized methods based on the homogeneous populations are warranted to validate the prognostic value of MET amplification in patients with NSCLC. |
format | Online Article Text |
id | pubmed-5968772 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-59687722018-05-25 Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis Kim, Jung Han Kim, Hyeong Su Kim, Bum Jun J Cancer Research Paper The alterations of MET have been detected in non-small-cell lung cancer (NSCLC). However, the prognostic impact of MET gene copy number gain (CNG) has not been consistent among studies. We performed this meta-analysis to evaluate the prognostic value of high MET CNG in patients with NSCLC. A systematic computerized search of the electronic databases including PubMed, EMBASE, Google scholar, and Cochrane Library (up to November 2017) was carried out. From twenty-one studies, 7,647 patients were included in the pooled analysis of hazard ratios (HRs) with 95% confidence intervals (CIs) for disease-free survival or overall survival. Compared with patients with NSCLC showing low MET CNG, those with tumors harboring high MET CNG showed significantly worse survival (HR = 1.45, 95% CI: 1.16-1.80, p = 0.001). Subgroup analyses showed that high MET CNG significantly correlated with a poor prognosis especially in patients with adenocarcinoma (HR = 1.41, 95% CI: 1.11-1.79, p = 0.005) and Asian populations (HR = 1.58, 95% CI: 1.32-1.88, p < 0.00001). In conclusion, this meta-analysis indicates that high MET CNG is an adverse prognostic factor in patients with NSCLC. Subgroup analyses suggest that high MET CNG is associated with a worse prognosis, especially in patients with adenocarcinoma and Asian populations. However, large prospective studies using standardized methods based on the homogeneous populations are warranted to validate the prognostic value of MET amplification in patients with NSCLC. Ivyspring International Publisher 2018-04-23 /pmc/articles/PMC5968772/ /pubmed/29805710 http://dx.doi.org/10.7150/jca.24980 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Kim, Jung Han Kim, Hyeong Su Kim, Bum Jun Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis |
title | Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis |
title_full | Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis |
title_fullStr | Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis |
title_full_unstemmed | Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis |
title_short | Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis |
title_sort | prognostic value of met copy number gain in non-small-cell lung cancer: an updated meta-analysis |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968772/ https://www.ncbi.nlm.nih.gov/pubmed/29805710 http://dx.doi.org/10.7150/jca.24980 |
work_keys_str_mv | AT kimjunghan prognosticvalueofmetcopynumbergaininnonsmallcelllungcanceranupdatedmetaanalysis AT kimhyeongsu prognosticvalueofmetcopynumbergaininnonsmallcelllungcanceranupdatedmetaanalysis AT kimbumjun prognosticvalueofmetcopynumbergaininnonsmallcelllungcanceranupdatedmetaanalysis |